1. Dihydroartemisinin inhibits catabolism in rat chondrocytes by activating autophagy via inhibition of the NF-κB pathway
    Li-Bo Jiang et al, 2016, Sci Rep CrossRef
  2. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway
    ZILAN LV et al, 2014 CrossRef
  3. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
    Thomas Efferth, 2017, Seminars in Cancer Biology CrossRef
  4. Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1
    Jie Yao et al, 2016 CrossRef
  5. Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
    WEI DU et al, 2015 CrossRef
  6. Antitumor Research on Artemisinin and Its Bioactive Derivatives.
    Yunqin Zhang et al, 2018, Nat Prod Bioprospect CrossRef
  7. Overexpression of PCDH8 inhibits proliferation and invasion, and induces apoptosis in papillary thyroid cancer cells
    Liang Chang et al, 2018, RSC Adv. CrossRef
  8. Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs
    Mongkol Pongsuchart et al, 2018, Cancer Sci CrossRef
  9. Opening of the CLC-3 chloride channel induced by dihydroartemisinin contributed to early apoptotic events in human poorly differentiated nasopharyngeal carcinoma cells.
    Congran Zhou et al, 2018, J Cell Biochem CrossRef
  10. Effects of Magnetic Dihydroartemisinin Nano-liposome in Inhibiting the Proliferation of Head and Neck Squamous Cell Carcinomas
    Li Hui et al, 2018, Phytomedicine CrossRef
  11. Chinese Herbal Medicine for Osteosarcoma in the Mouse: A Systematic Review and Meta-Analysis
    Jun-li Chang et al, 2018, Chin. J. Integr. Med. CrossRef
  12. Effects of dihydroartemisinin on HSP70 expression in human prostate cancer PC‐3 cells
    Jin Kong et al, 2019, Andrologia CrossRef
  13. Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic
    Yu Cai et al, 2014, J. Cell. Biochem. CrossRef
  14. A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control
    Xu-Guang Zhang et al, 2014, Parasitol Res CrossRef
  15. TIKI2 suppresses growth of osteosarcoma by targeting Wnt/β-catenin pathway.
    Ruhui Li et al, 2014, Mol. Cell. Biochem. CrossRef
  16. Wnt/β-catenin pathway in bone cancers.
    Jian Tian et al, 2014, Tumour Biol CrossRef
  17. Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis
    Ge Xu et al, 2016, Life Sciences CrossRef
  18. Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors
    Riccardo Zanni et al, 2015, PLoS ONE CrossRef
  19. Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt/β-catenin pathway
    Hai-ying Hui et al, 2016, Anti-Cancer Drugs CrossRef
  20. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway
    Wei-Guo Wang et al, 2016, Tumor Biol. CrossRef
  21. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis
    Yue Li et al, 2020, ACAMC CrossRef
  22. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats
    Ming Tang et al, 2020 CrossRef
  23. Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer
    Jianqing Peng et al, 2021, Front. Pharmacol. CrossRef
  24. Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death
    Annemarie Ackermann et al, 2021, Sci Rep CrossRef
  25. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis
    Rui-jia Wen et al, 2023, Phytomedicine CrossRef
  26. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
    Ziyu Ji et al, 2023, MedComm CrossRef